Thermo Fisher Scientific, inaugurated two new facilities in Hyderabad’s Genome Valley. The Bioprocess Design Center (BDC), a technology scale-up facility, was set up in partnership with the Government of Telangana; other partners are the Department of Biotechnology, Ministry of Science & Technology, Government of India, under the Biotech Park Project.

The Customer Experience Centre serves as a collaborative hub for scientists, entrepreneurs, and industry professionals, offering hands-on training and co-development opportunities. The center demonstrates over 50 integrated workflows across 20+ applications in targeted therapeutics like cell and gene therapy, mRNA, oncology, proteomics, and analytical sciences, featuring Thermo Fisher’s flagship technologies.

The centres will support 200 to 250 researchers and scientists annually, providing access to advanced technologies, hands-on training, and collaborative programmes that accelerate innovation across bioprocessing, analytical sciences, healthcare, clean energy, and semiconductors.

Developed in collaboration with the Government of Telangana, the centres align with the Telangana Life Sciences Mission to position the state as a global life sciences innovation hub.

D Sridhar Babu, Minister of IT and Industries, Telangana, said, “Telangana’s life sciences sector is on a strong growth trajectory. Partnerships like this will help us achieve our target of Rs 1 trillion in life sciences investments by 2030. Thermo Fisher’s new centres bring global capabilities that strengthen our ecosystem. These new facilities will create opportunities for collaboration and skill-building, while reinforcing our vision of making Telangana the life sciences capital of the world.”

The Bioprocess Design Centre complements the CEC with bench-to-pilot-scale capabilities for biologics and vaccine manufacturing. It enables rapid prototyping, process optimisation, and scale-up using single-use systems, supported by laboratories for cell culture, microbial fermentation, purification, and analytical testing.

Tony Acciarito, President, Asia Pacific and Middle East, Africa Thermo Fisher Scientific, said, “India’s life sciences sector is at an inflection point. These new centres reinforce our commitment to supporting the region’s growth through meaningful collaborations that help researchers and industry partners move from ideas to impact faster.”

Srinath Venkatesh, Managing Director, India and South Asia, Thermo Fisher Scientific, said, “We are committed to enabling a sustainable ecosystem that integrates talent, infrastructure, and cutting-edge technology, strengthening India’s position on the global biopharma and life sciences stage. Expanding our capability footprint through these centres demonstrate our vision to be the preferred partner for innovation, development, and manufacturing within the country.”

With a combined investment of Rs 850–900 million in the CEC and BDC, Thermo Fisher continues to build on its investments and growing presence in India.